Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
Most people are familiar with melanoma as a skin cancer, but melanoma can impact the eyes as well. Brian Marr, MD, offers tips on how to protect your eyes.
A new study in mice, led by Columbia University researchers, suggests experimental eye drops may be more effective than injections for treatment of retinal vein occlusion, a major cause of blindness.
Columbia researchers have found hundreds of genes linked to nearsightedness, and now they’re using the data to screen for new drugs that can safeguard sharp vision.
Vagelos student Emery Jamerson’19 received the 2018 Dr. David K. McDonogh Scholarship in Ophthalmology/ENT, named for the first black Columbia-trained doctor in New York.
The most common tests for glaucoma can underestimate the severity of the condition because they do not detect the presence of central vision loss, ophthalmologists at Columbia have found.
The discovery of genes that control eye growth gives researchers critical information in the search for drugs that can prevent nearsightedness, the world’s most common eye disorder.